SiriusPoint Croissance future
Future contrôle des critères 0/6
Les bénéfices de SiriusPoint devraient diminuer de 16.5% par an tandis que son chiffre d'affaires annuel devrait croître de 6.2% par an. Le BPA devrait croître de diminuer de 10.7% par an. Le rendement des capitaux propres devrait être 12.4% dans 3 ans.
Informations clés
-16.5%
Taux de croissance des bénéfices
-10.73%
Taux de croissance du BPA
| Insurance croissance des bénéfices | 2.0% |
| Taux de croissance des recettes | 6.2% |
| Rendement futur des capitaux propres | 12.40% |
| Couverture par les analystes | Low |
| Dernière mise à jour | 17 Apr 2026 |
Mises à jour récentes de la croissance future
Recent updates
Mise à jour de l'analyse • May 04
SPNT: Reorganization And Buy Rating Will Test Execution And Earnings Resilience
Analysts have modestly raised their $23.00 price target on SiriusPoint, reflecting updated assumptions around revenue, profit margins, and future P/E. This revision is supported by renewed Buy-rated coverage from the Street.Mise à jour de l'analyse • Apr 20
SPNT: Neutral Outlook Will Weigh Reorganization Benefits Against Execution And Earnings Risks
Analysts have adjusted their SiriusPoint price target to $23.00, with the change supported by updated assumptions around slightly higher revenue growth, an improved profit margin outlook, and a lower future P/E multiple. Analyst Commentary Recent Street research around SiriusPoint centers on whether the current share price already reflects the updated $23.00 target, especially given the revised assumptions on revenue, margins, and a lower future P/E multiple.Mise à jour de l'analyse • Apr 03
SPNT: Neutral Outlook Will Balance Capital Moves With Execution And Earnings Risks
The analyst price target for SiriusPoint has increased from $22 to $23, with analysts citing revised assumptions around fair value, revenue growth, profit margin, and future P/E to support this change. Analyst Commentary Recent research coverage has taken a measured stance on SiriusPoint, with the new analysis tending to frame the current price target in the context of execution risk, valuation assumptions, and the durability of earnings.
Mise à jour de l'analyse • Mar 20
SPNT: Neutral Coverage And Capital Moves Will Set Up Bullish Repricing
Analysts trimmed their price target on SiriusPoint by $0.59 due to slightly lower profit margin assumptions and a higher future P/E multiple following recent neutral research coverage. Analyst Commentary Recent neutral research coverage frames SiriusPoint as fairly balanced at current levels, with the trimmed price target reflecting fine tuning of profit margin expectations and a higher assumed future P/E multiple rather than a major shift in the core thesis.Seeking Alpha • Mar 13
Tracking Dan Loeb's Third Point Portfolio - Q4 2025 Update
Summary Third Point’s Q4 2025 13F portfolio shrank to $7.27B, with top holdings in PG&E, Nvidia, Amazon, Microsoft, and Union Pacific. Significant stake increases occurred in NVDA, UNP, CRH, SGI, BN, LYV, MTZ, and VST, reflecting conviction in these names despite overall portfolio contraction. New positions were initiated in CMG and CEG at higher prices than current levels, while major exits included FLUT, META, APO, and several smaller holdings. Portfolio remains highly concentrated, with 22% in the top three names, and recent moves show active management in response to market price shifts. Read the full article on Seeking AlphaMise à jour de l'analyse • Mar 06
SPNT: Neutral Rating And Share Actions Will Set Up Rerating Potential
Narrative Update on SiriusPoint Analysts have reset their price target on SiriusPoint from $27.50 to $24.00, citing revised assumptions around growth, profitability, discount rates and a higher future P/E multiple, alongside recent neutral research coverage. Analyst Commentary Recent research coverage on SiriusPoint has taken a neutral stance overall, focusing on how updated assumptions around growth, profitability and discount rates line up with the new US$24.00 price target.Mise à jour de l'analyse • Feb 19
SPNT: Neutral Stance Will Weigh Capital Simplification Against Execution Risks
Analysts have maintained their $22.00 price target on SiriusPoint, citing updated assumptions for revenue growth, profit margins, and future P/E, along with the recent neutral initiation of coverage by Raymond James. Analyst Commentary Recent research commentary around SiriusPoint has leaned cautious, with the neutral initiation signaling that some analysts see a balance between potential upside and key execution risks.Mise à jour de l'analyse • Feb 05
SPNT: Neutral Outlook Will Weigh Capital Simplification Against Execution Risks
Analysts have lifted their price target on SiriusPoint from US$21.00 to US$22.00, citing updated assumptions around revenue growth, profit margins, and future P/E as key drivers of the change. Analyst Commentary Recent Street research on SiriusPoint, including a neutral initiation, points to a more balanced view, where potential upside is weighed against clear execution and valuation risks.Mise à jour de l'analyse • Oct 04
Rising Global Reinsurance Demand Will Unlock Specialty Potential
Analysts have raised their price target for SiriusPoint from $25.33 to $27.50. This reflects a more optimistic outlook based on slightly higher projected revenue growth and modest adjustments in key valuation metrics.Article d'analyse • Jul 24
Potential Upside For SiriusPoint Ltd. (NYSE:SPNT) Not Without Risk
With a price-to-earnings (or "P/E") ratio of 15.4x SiriusPoint Ltd. ( NYSE:SPNT ) may be sending bullish signals at the...Nouvelle analyse • Jun 29
Refined Underwriting And Climate Reinsurance Will Unlock Opportunities
Enhanced specialty underwriting and analytics are driving sustainable earnings growth, increased profitability, and improved operating efficiency.Article d'analyse • May 14
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For SiriusPoint Ltd.'s (NYSE:SPNT) CEO For Now
Key Insights SiriusPoint will host its Annual General Meeting on 20th of May CEO Scott Egan's total compensation...Article d'analyse • Mar 13
It's A Story Of Risk Vs Reward With SiriusPoint Ltd. (NYSE:SPNT)
With a price-to-earnings (or "P/E") ratio of 13.3x SiriusPoint Ltd. ( NYSE:SPNT ) may be sending bullish signals at the...Article d'analyse • Aug 26
Not Many Are Piling Into SiriusPoint Ltd. (NYSE:SPNT) Just Yet
There wouldn't be many who think SiriusPoint Ltd.'s ( NYSE:SPNT ) price-to-sales (or "P/S") ratio of 0.9x is worth a...Article d'analyse • May 08
Investors Holding Back On SiriusPoint Ltd. (NYSE:SPNT)
There wouldn't be many who think SiriusPoint Ltd.'s ( NYSE:SPNT ) price-to-sales (or "P/S") ratio of 0.8x is worth a...Seeking Alpha • Mar 06
Tracking Dan Loeb's Third Point Portfolio - Q4 2023 Update
Summary Dan Loeb's 13F portfolio value increased to $6.64B this quarter, with the top three holdings accounting for ~37% of the portfolio. Third Point returned 3.4% in 2023 compared to 26.3% for the S&P 500 Index. New stakes include Fleetcor Tech, Verizon, Apollo Global Management, McKesson Corp, EQT Corp, and Biomarin Pharma. Read the full article on Seeking AlphaArticle d'analyse • Jan 23
SiriusPoint Ltd. (NYSE:SPNT) Could Be Riskier Than It Looks
With a median price-to-sales (or "P/S") ratio of close to 1x in the Insurance industry in the United States, you could...Seeking Alpha • Jan 22
Revisiting SiriusPoint Common And Preferred
Summary SiriusPoint's preferred units have shot up nicely in recent months, generating strong returns for shareholders. SPNT's financial health has improved, with increased profits and a decline in some activities. The common units are still rated a 'buy' due to increased profitability, but the limited upside that remains necessitates a downgrade for the preferred units. Read the full article on Seeking AlphaSeeking Alpha • Sep 25
SiriusPoint Offers Extremely Undervalued 9.3% Bond And An Excellent Preferred Stock
Summary We first revisit our recommendation of SiriusPoint preferred stock from May of this year. Although SPNT-B has been a big winner for us since May, it is still the most undervalued among “qualified” BB+ rated preferred stocks plus it has a massive reset rate. At the current 5-year treasury note yield, the reset yield on SPNT-B will be 12% and it trades below par. SiriusPoint also offers an extremely undervalued bond with an investment grade BBB rating and an approximate 9.3% yield-to-maturity (YTM). A typical BBB bond has a YTM of around 6.3% making this 9.3% YTM bond the most undervalued bond in the market based on credit rating (in my opinion). Read the full article on Seeking AlphaSeeking Alpha • Feb 23
SiriusPoint GAAP EPS of -$0.17, revenue of $673.6M
SiriusPoint press release (NYSE:SPNT): Q4 GAAP EPS of -$0.17. Revenue of $673.6M (+69.2% Y/Y). Combined ratio of 90.4%, underwriting income of $58M. Core income of $25M. Net investment income of $52M. Tangible book value per diluted common share decreased $0.15, or 1.4%, from September 30, 2022 to $10.43 per share. Annualized return on average common equity of (5.7)%.Seeking Alpha • Oct 12
SiriusPoint appoints Steve Yendall as CFO
Insurer SiriusPoint (NYSE:SPNT) on Wednesday said it had appointed Steve Yendall as CFO, effective October 31, 2022. Yendall replaces David Junius, the company said in a statement. According to SPNT, Yendall is a 25-year veteran of the re/insurance industry, and was most recently managing director at Guy Carpenter, Canada and North America. SiriusPoint (SPNT) stock earlier closed -6.1% at $4.60.Seeking Alpha • Sep 07
Scott Egan is the new CEO of SiriusPoint
SiriusPoint (NYSE:SPNT) appoints Scott Egan as the company’s Chief Executive Officer, effective September 21st, 2022. Most recently the Chief Executive of Royal Sun Alliance UK & International, and a FTSE 100 board director for six years, Egan brings over 25 years of insurance industry experience to the company.Seeking Alpha • Aug 03
SiriusPoint GAAP EPS of -$0.38, revenue of $473.1M
SiriusPoint press release (NYSE:SPNT): Q2 GAAP EPS of -$0.38. Revenue of $473.1M (-15.7% Y/Y).Prévisions de croissance des bénéfices et des revenus
| Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
|---|---|---|---|---|---|
| 12/31/2028 | 3,619 | N/A | N/A | 736 | 1 |
| 12/31/2027 | 3,401 | 325 | N/A | 692 | 2 |
| 12/31/2026 | 3,255 | 310 | N/A | 636 | 2 |
| 12/31/2025 | 2,983 | 443 | 102 | 102 | N/A |
| 9/30/2025 | 2,859 | 186 | 237 | 237 | N/A |
| 6/30/2025 | 2,794 | 106 | 139 | 139 | N/A |
| 3/31/2025 | 2,682 | 149 | -73 | -73 | N/A |
| 12/31/2024 | 2,656 | 176 | 75 | 75 | N/A |
| 9/30/2024 | 2,674 | 281 | 180 | 180 | N/A |
| 6/30/2024 | 2,697 | 330 | 284 | 284 | N/A |
| 3/31/2024 | 2,820 | 277 | 546 | 546 | N/A |
| 12/31/2023 | 2,795 | 315 | 581 | 581 | N/A |
| 9/30/2023 | 2,810 | 201 | 416 | 416 | N/A |
| 6/30/2023 | 2,704 | 49 | 454 | 454 | N/A |
| 3/31/2023 | 2,418 | -64 | 387 | 387 | N/A |
| 12/31/2022 | 2,078 | -403 | 293 | 293 | N/A |
| 9/30/2022 | 1,830 | -506 | 220 | 220 | N/A |
| 6/30/2022 | 1,963 | -456 | 34 | 34 | N/A |
| 3/31/2022 | 2,049 | -333 | 51 | 51 | N/A |
| 12/31/2021 | 2,130 | 41 | 2 | 2 | N/A |
| 9/30/2021 | 2,119 | 305 | 55 | 55 | N/A |
| 6/30/2021 | 1,652 | 421 | 55 | 55 | N/A |
| 3/31/2021 | 1,362 | 484 | 28 | 28 | N/A |
| 12/31/2020 | 890 | 142 | 73 | 73 | N/A |
| 9/30/2020 | 751 | 39 | 90 | 90 | N/A |
| 6/30/2020 | 689 | -45 | 74 | 74 | N/A |
| 3/31/2020 | 636 | -116 | 115 | 115 | N/A |
| 12/31/2019 | 983 | 200 | 141 | 141 | N/A |
| 9/30/2019 | 656 | -128 | N/A | 88 | N/A |
| 6/30/2019 | 582 | -126 | N/A | 98 | N/A |
| 3/31/2019 | 540 | -159 | N/A | 73 | N/A |
| 12/31/2018 | 377 | -318 | N/A | 13 | N/A |
| 9/30/2018 | 639 | 25 | N/A | -88 | N/A |
| 6/30/2018 | 699 | 93 | N/A | -48 | N/A |
| 3/31/2018 | 807 | 147 | N/A | -97 | N/A |
| 12/31/2017 | 933 | 278 | N/A | -79 | N/A |
| 9/30/2017 | 894 | 187 | N/A | 31 | N/A |
| 6/30/2017 | 924 | 204 | N/A | -41 | N/A |
| 3/31/2017 | 862 | 183 | N/A | -27 | N/A |
| 12/31/2016 | 692 | 28 | N/A | 5 | N/A |
| 9/30/2016 | 729 | 116 | N/A | 2 | N/A |
| 6/30/2016 | 528 | -151 | N/A | 85 | N/A |
| 3/31/2016 | 463 | -189 | N/A | 83 | N/A |
| 12/31/2015 | 574 | -87 | N/A | 188 | N/A |
| 9/30/2015 | 559 | -144 | N/A | 258 | N/A |
| 6/30/2015 | 639 | 45 | N/A | 228 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: Les bénéfices de SPNT devraient diminuer au cours des 3 prochaines années ( -16.5% par an).
Bénéfices vs marché: Les bénéfices de SPNT devraient diminuer au cours des 3 prochaines années ( -16.5% par an).
Croissance élevée des bénéfices: Les bénéfices de SPNT devraient baisser au cours des trois prochaines années.
Chiffre d'affaires vs marché: Le chiffre d'affaires de SPNT ( 6.2% par an) devrait croître plus lentement que le marché de US ( 11.5% par an).
Croissance élevée des revenus: Le chiffre d'affaires de SPNT ( 6.2% par an) devrait croître plus lentement que 20% par an.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Le retour sur capitaux propres de SPNT devrait être faible dans 3 ans ( 12.4 %).
Découvrir les entreprises en croissance
Analyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/05/07 05:02 |
| Cours de l'action en fin de journée | 2026/05/07 00:00 |
| Les revenus | 2025/12/31 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
SiriusPoint Ltd. est couverte par 7 analystes. 3 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Jay Cohen | BofA Global Research |
| Randy Binner | B. Riley Securities, Inc. |
| Timothy D'Agostino | B. Riley Securities, Inc. |